Groups tell Congress to back off fight over ESA dosing decisions
Groups say cancer drug dosing best measured by CMS, Medicaid.
A handful of consumer and health groups have fired the latest salvo in the ongoing battle over Medicare reimbursements for anemia drugs. In a letter sent Wednesday to Congress, the groups-including Consumers Union, U.S. PIRG, the National Research Center for Women & Families, the National Women's Health Network, and the Center for Medical Consumers-urged lawmakers to back off the fight over a CMS
Recent Videos
Related Content
Q&A: How Specific GLP-1s Impact Different Patient Populations | ASHP Midyear
Brian Nowosielski;Jennifer Clements, PharmD, BCACP, BC-ADM, BCPS, CDCES, FADCES, FCCP;Ashley Gallagher
January 13th 2025Article
Jennifer Clements, PharmD, BCACP, BC-ADM, BCPS, CDCES, FADCES, FCCP, discussed current GLP-1 medication offerings and how each impacts patients differently.
